COMMUNIQUÉS West-GlobeNewswire

The Canadian Dermatology Association Announces 2024 Award Recipients
03/07/2024
OTTAWA, Ontario, July 03, 2024 (GLOBE NEWSWIRE) -- The Canadian Dermatology Association (CDA) is proud to announce this year’s recipients of its Member Awards and Public Education Awards, following a detailed review of [...]
L’Association canadienne de dermatologie annonce les lauréats de ses prix de 2024
03/07/2024
OTTAWA, Ontario, 03 juill. 2024 (GLOBE NEWSWIRE) -- L’Association canadienne de dermatologie (ACD) est ravie d’annoncer les lauréats des Prix des membres et des Prix d’éducation publique de cette année. Le Comité des [...]
BC Platforms Announces Appointment of New Chairman, Alex Dickinson
03/07/2024
Serial entrepreneur and precision medicine technologist to drive strategic agenda at BC Platforms ZURICH, July 03, 2024 (GLOBE NEWSWIRE) -- BC Platforms, a global leader in real world data, healthcare data management, [...]
Immutep Announces Details for Oral Presentation at ESMO Virtual Plenary Session and Webcast to Discuss Clinical Results
03/07/2024
Company to Host Webcast on 12th July at 9am AEST (7pm ET, 11 July) SYDNEY, AUSTRALIA, July 03, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage [...]
Apollomics Announces Updated Strategic Focus and Leadership Team Changes
03/07/2024
Focus on vebreltinib study enrollment for non-small cell lung cancer (NSCLC) patients with Met Amplification mutations targets greatest unmet medical need FOSTER CITY, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- [...]
IntelGenx Obtains Preliminary Efficacy Results for the ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease
03/07/2024
MONTREAL, July 03, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (the “Company” or “IntelGenx” a subsidiary of IntelGenx Technologies Corp.) (OTCQB: IGXT; TSX: IGX), has successfully completed the BUENA Alzheimer’s disease ( [...]
Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
03/07/2024
UPPSALA, Sweden, July 03, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK), a global leader in proteomics, introduces its inaugural network of Olink ® Certified Service Providers. The group of Olink [...]
CorMedix Inc. Announces Outpatient Availability of DefenCath
03/07/2024
BERKELEY HEIGHTS, N.J., July 03, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today [...]
Skye Bioscience Appoints Dr. Karen Smith to Board of Directors
03/07/2024
Seasoned industry veteran adds significant global biotech and biopharma experience to Skye’s Board of Directors SAN DIEGO, July 03, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) ("Skye" or the "Company [...]
Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors
02/07/2024
Jeff Dykan, who led Lifeward as Chairman of its Board through the past 15 years, has announced his intent to retire at the end of his current term MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, July 02, 2024 (GLOBE [...]
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2024
SAN FRANCISCO, July 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
02/07/2024
RADNOR, Pa., July 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2024 [...]
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2024
WALTHAM, Mass. and DUBLIN, July 02, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to [...]
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024
02/07/2024
-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell and Gene Therapy Facilities [...]
Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik
02/07/2024
Dr. Malik to deepen strategic leadership and provide regulatory and clinical development innovation expertise GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “ [...]
BrightSpring Health Services, Inc. to Announce Second Quarter 2024 Financial Results on August 2, 2024
02/07/2024
LOUISVILLE, Ky., July 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its second quarter 2024 financial results [...]
Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
02/07/2024
SAN DIEGO, July 02, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on a variety of chronic [...]
Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
02/07/2024
IRVINE, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the Company’s management team will be hosting one-on-one meetings at the Leerink Partners [...]
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
02/07/2024
SAN DIEGO, July 02, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]

Pages